Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N03AX11	TOPIRATE 25 BENTA	G	Topiramate - 25mg	25mg	Tablet, film coated	671,921 L.L
N05BA12	TRANQUINAL 0.5 SUBLINGUAL	G	Alprazolam - 0.5mg	0.5mg	Tablet, sublingual	459,594 L.L
P02CA03	ALBENDA	G	Albendazole - 100mg/5ml	400mg/20ml	Suspension	129,009 L.L
V03AC03	DEFERASIROX ARROW	G	Deferasirox - 180mg	180mg	Tablet, coated	9,056,837 L.L
A02BC03	JOSWE LANZOTEC 30	G	Lansoprazole - 30mg	30mg	Capsule	514,692 L.L
B05CX01	DEXTROSE 7.5% INJECTION USP	G	Glucose - 7.5%	7.5%	Injectable solution	163,184 L.L
C05AE03	DILTIGEL	G	Diltiazem HCl - 2%	2%	Gel	632,950 L.L
C09CA04	ZIOREL	G	Irbesartan - 300mg	300mg	Tablet, film coated	575,933 L.L
C10AA07	SINLIP	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	563,070 L.L
D10AD51	RETINOMYCIN	G	Tretinoin - 0.025%, Erythromycin - 4%		Gel	662,962 L.L
G04BE08	TYRA	G	Tadalafil - 5mg	5mg	Tablet, film coated	3,566,558 L.L
J01CR05	YANOVEN	G	Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g		Injectable powder for solution	10,860,623 L.L
J01MA02	VONECIP	G	Ciprofloxacin - 200mg/100ml	200mg/100ml	Injectable solution	579,196 L.L
L02BG06	EXEMESTANE GENEPHARM	G	Exemestane - 25mg	25mg	Tablet, film coated	1,286,662 L.L
M01AB16	LOFLAM	G	Aceclofenac - 100mg	100mg	Tablet	767,334 L.L
N01BB02	LIDOCAINE- ORBUCELL	G	Lidocaine HCl - 1%	1%	Injectable solution	1,787,950 L.L
N03AX11	TORAMAT	G	Topiramate - 25mg	25mg	Tablet, film coated	522,755 L.L
N05BA25	SEDOXIL	G	Mexazolam - 1mg	1mg	Tablet	1,705,336 L.L
P02CA03	ALBENDA	G	Albendazole - 200mg	200mg	Tablet	116,914 L.L
V03AC03	DEFEROXAL 180	G	Deferasirox - 180mg	180mg	Tablet, film coated	13,424,141 L.L
A02BC03	LPZ-30	G	Lansoprazole - 30mg	30mg	Capsule, delayed release	360,150 L.L
B02BX05	APO-ELTROMBOPAG	G	Eltrombopag Olamine - 50mg	50mg	Tablet	75,952,887 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 10g/20ml	50%	Injectable solution	5,038,066 L.L
C05AX	HEMOCARE	G	Bismuth subgallate - 100mg, Zinc oxide - 100mg, Lidocaine - 60mg		Suppository	588,731 L.L
C10AA07	SUPERSTAT	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, coated	517,379 L.L
D10AD51	CLINIDERM T	G	Tretinoin - 0.025%, Clindamycin (phosphate) - 1%		Gel	801,186 L.L
G04BE08	APO-TADALAFIL	G	Tadalafil - 10mg	10mg	Tablet	888,280 L.L
J01CR50	FLUMOX	G	Flucloxacillin (monohydrate) - 250mg, Amoxicillin (trihydrate) - 250mg		Capsule	348,055 L.L
J01MA02	CEFLOXINE	G	Ciprofloxacin - 400mg/200ml	400mg/200ml	Injectable solution	1,134,203 L.L
L02BG06	EXEMESTANE PHARMINICIO	G	Exemestane - 25mg	25mg	Tablet, film coated	1,158,392 L.L